Mandate

Vinge advises Lantmännen in connection with the divestment of Swecon to Volvo Construction Equipment

Lantmännen Ek för has signed an agreement to divest Swecon to Volvo Construction Equipment (Volvo CE). Volvo CE will pay SEK 7 billion for the acquisition. The transaction is subject to regulatory approvals and is expected to be completed during the second half of 2025.

The transaction includes Swecon’s entire business scope, i.e. sales of products and services, rental operations, aftermarket services and customer support as well as offices, workshop facilities and 1,400 employees. The deal also includes Entrack. Swecon has been part of Lantmännen since its inception 25 years ago, and Swecon’s net sales in 2024 amounted to 10 billion SEK. Volvo CE sees this as a strategic move to further invest in retail operations in key markets; Germany, which is Europe’s largest construction equipment market, Sweden, Volvo CE´s home market as well as Estonia, Latvia and Lithuania. In addition to the currently owned retail operations footprint, this acquisition will mean Volvo CE will own and manage the majority of the company´s business in Europe, making retail core for Volvo CE in Europe. 

Vinges team mainly consisted of Christina Kokko, Gustav Wahlberg, Alex Forsberg and Josef Groow (M&A), Eva Fredriksson and Elis Allmark (IT/TSA), Marcus Glader and Hampus Peterson (EU, Competition and Regulatory) Christoffer Nordin (Commercial agreements) and Johanna Engström and Emy Rydén (Transaction Support Coordinators). 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025